Effects of Oral Aloe Vera Juice on Chemotherapy and Radiation-induced Oral Mucositis and Esophagitis
NCT ID: NCT05369234
Last Updated: 2024-10-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
100 participants
INTERVENTIONAL
2022-01-20
2024-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Efficacy of Aloe-Vera el Versus Bezydamine Hydrochloride in the Prevention of Radiation Induced Oral Mucositis A Randamized Controlled Clinical Trial
NCT06879366
Effect of Aloe Vera Gel and Manuka Honey on Radiation Induced Oral Mucositis
NCT06381635
Comparison Between the Effect of Aloe Vera and Benzydamine Hydrochloride Mouth Gel on Prevention of Pain and Progression of Radiation-induced Oral Mucositis
NCT06862817
Magic Mouthwash Plus Sucralfate Versus Benzydamine Hydrochloride for the Treatment of Radiation-induced Mucositis
NCT00814359
The Use of Tulsi Extract for The Management of Oral Mucositis in Head & Neck Cancer Patients Undergoing Radiotherapy
NCT05323058
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this study, the aloe vera juice that will be utilized by the patients is George's 100% Aloe Vera Juice, manufactured by Warren Laboratories. This aloe vera juice has been fractionally distilled to remove anthraquinone and other compounds that can cause nausea, abdominal cramping, and diarrhea, as well as bitter, unpleasant taste.
This study aims to add to the existing body of research around aloe vera juice and its effects on oral mucositis and esophagitis. The intention is to determine whether aloe vera juice, in combination with standard treatments, is more effective in management of oral mucositis and esophagitis than standard treatment alone. If so, aloe vera offers a natural, cost-effective option for managing radiation and chemotherapy side effects.
Patients in arm 1 of cohort 1 or 2 will be given 3 gallons of George's 100% Aloe Vera Liquid Supplement, free of cost, to utilize throughout treatment. Patients in cohort 1, arm 2 will be asked to swish and spit ¼ cup (2 ounces) of the aloe vera juice 3 times per day, 7 days per week while they are on radiation treatment. Patients in cohort 2, arm 2 will be asked to drink ¼ cup (2 ounces) of aloe vera juice 3 times per day, 7 days per week while they are on chemotherapy and radiation treatment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
Cohort 2--Esophageal, mediastinal, chest wall cancers receiving chemotherapy and radiation will be randomized to receiving aloe vera juice + standard of care treatments or standard of care treatments.
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort 1--Arm 1
Aloe Vera Juice + Standard of Care Treatments Swish and spit ¼ cup (2 ounces) of 100% aloe vera juice 3 times per day, 7 days per week as first line treatment, standard of care agents added as needed
100% Aloe Vera Juice
George's 100% Aloe Vera Liquid Supplement
Magic Mouthwash
Magic Mouthwash
Salt and Baking soda rinse
Mouth rinse made with salt and baking soda
Carafate
Carafate taken as a slurry
Cohort 1--Arm 2
Standard of Care Treatments Use salt and baking soda rinses, Magic Mouthwash, Carafate, etc.
Magic Mouthwash
Magic Mouthwash
Salt and Baking soda rinse
Mouth rinse made with salt and baking soda
Carafate
Carafate taken as a slurry
Cohort 2--Arm 1
Aloe Vera Juice + Standard of Care Treatments Drink ¼ cup (2 ounces) of 100% aloe vera juice 3 times per day, 7 days per week as first line treatment, standard of care agents added as needed
100% Aloe Vera Juice
George's 100% Aloe Vera Liquid Supplement
Magic Mouthwash
Magic Mouthwash
Salt and Baking soda rinse
Mouth rinse made with salt and baking soda
Carafate
Carafate taken as a slurry
Cohort 2-- Arm 2
Standard of Care Treatments Use salt and baking soda rinses, Magic Mouthwash, Carafate, etc.
Magic Mouthwash
Magic Mouthwash
Salt and Baking soda rinse
Mouth rinse made with salt and baking soda
Carafate
Carafate taken as a slurry
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
100% Aloe Vera Juice
George's 100% Aloe Vera Liquid Supplement
Magic Mouthwash
Magic Mouthwash
Salt and Baking soda rinse
Mouth rinse made with salt and baking soda
Carafate
Carafate taken as a slurry
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \>/= 18 years
* Confirmed lip, oral cavity, hard palate, tongue, tonsil, pharyngeal, neck, esophageal, mediastinal, and/or chest wall cancers
* Women of child-bearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry and for the duration of study participation.
* Men treated or enrolled on this protocol must agree to use adequate contraception prior to the study, for the duration of study participation.
Exclusion Criteria
* History of allergic reactions attributed to compounds of similar chemical or biologic composition to aloe vera juice.
* Patients with psychiatric illness/social situations that would limit compliance with study requirements.
* Pregnant women or women who are breastfeeding
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Thompson Cancer Survival Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Daniel Scaperoth, MD
Role: PRINCIPAL_INVESTIGATOR
Thompson Cancer Survival Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Thompson Cancer Survival Center Radiation Oncology Services
Knoxville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-404 INV Aloe_Oncology
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.